Photo of Tim Scott
R United States Senate · South Carolina

Sen. Tim Scott

Compare
Total votes
1,044
all sessions
Attendance
94%
67 missed
Near the chamber average
With party
96%
of cast votes
Higher than 95% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Lower than 97% of chamber peers
Sponsored
940
bills & resolutions
Lower than 85% of chamber peers
Committees
15
assignments
940 bills and resolutions

Sponsored bills

Total
940
Primary
172
Co-sponsor
768
This page
940
matching current filters
Co-sponsor S 2790
In committee · Nebraska Senate · Co-sponsor
Consumer Financial Protection Bureau Accountability Act of 2021

Consumer Financial Protection Bureau Accountability Act of 2021 This bill changes the source of funding for the Consumer Financial Protection Bureau (CFPB) from Federal Reserve System transfers to annual appropriations. Under current law, the transfers from the Federal Reserve System permit the CFPB to be funded outside of the annual appropriations process.

In committee Sep 21, 2021 1 co-sponsor
Co-sponsor S 2778
In committee · Nebraska Senate · Co-sponsor
Teachers and School LEADERS Act of 2021

Teachers and School Leaders need Education And Development to be Empowered Resources in Schools Act of 2021 or the Teachers and School LEADERS Act of 2021 This bill reauthorizes through FY2027 and otherwise revises the Teacher Quality Partnership program. This grant program provides training and professional development opportunities for prospective and new teachers through partnerships between (1) high-need school districts, schools, or early childhood education programs; and (2) institutions of higher education. Specifically, the bill expands the program to include training and professional development opportunities for principals and other school leaders. In addition, the bill expands the types of entities that qualify as partners to high-need schools or programs to include entities that are educational organizations, entities operating programs that provide alternative routes to state certification of teachers or school leaders, or educational service agencies.

In committee Sep 21, 2021 1 co-sponsor
Co-sponsor S 2756
In committee Sep 15, 2021 1 co-sponsor
Co-sponsor S 2721
In committee · Nebraska Senate · Co-sponsor
A bill to require the Internal Revenue Service to issue a report on the tax gap, to establish a fellowship program within the Internal Revenue Service to recruit mid-career tax professionals to create and participate in an audit task force, and for other purposes.

This bill requires the Internal Revenue Service (IRS) to report to Congress on projections of the estimated tax gap (i.e., the difference between tax liabilities owed to the IRS and those liabilities that the IRS actually collects). The IRS may use artificial intelligence and related data analysis tools to calculate a tax gap projection. The bill also requires the Joint Committee on Taxation to issue periodic reports to the congressional tax committees on the tax gap projection. The bill restricts IRS funding to FY2021 levels for audits and enforcement until it publishes an updated tax gap projection. Funding is also restricted for certain purposes, including (1) targeting U.S. citizens who exercise their First Amendment rights, (2) targeting a group for regulatory scrutiny based on its ideological beliefs, and (3) auditing individual taxpayers with an adjusted gross income of less than $400,000. The bill directs the IRS to establish a fellowship program to recruit private sector tax experts to join the IRS to create and participate in the audit task force. The purposes of the tax force include performing audit case selection, educating IRS employees on emerging issues, auditing selected taxpayers, addressing offshore tax evasion, and identifying, mentoring, and training IRS junior employees with respect to audits.

In committee Sep 13, 2021 1 co-sponsor
Primary S 2690
In committee · Nebraska Senate · Lead sponsor
Expanding Access to Affordable Credit for Small Businesses Act

Expanding Access to Affordable Credit for Small Businesses Act This bill establishes rules related to the authorization of lending institutions and other entities (including small business lending companies, non-federally regulated lenders, and non-depository lending institutions) to make loans under the 7(a) Program of the Small Business Administration (SBA). Under the 7(a) Program, the SBA provides business loans and loan guarantees to small business borrowers who cannot obtain credit elsewhere on reasonable terms and conditions. Specifically, the SBA must ensure that these lending institutions and other entities (1) provide an independent audit that examines adherence to all applicable federal laws and regulations regarding anti-money laundering, counterterrorist financing, sanctions, and financial crimes; and (2) implement a compliance program that is designed to conform with relevant anti-money laundering laws and regulations.

In committee Aug 10, 2021 0 co-sponsors
Co-sponsor S 2706
In committee · Nebraska Senate · Co-sponsor
DIVERSE Trials Act

Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act or the DIVERSE Trials Act This bill requires activities to increase diversity in clinical trials. It also expands reporting by laboratories that test for and diagnose COVID-19 and requires a study on data collection and data sharing during public health emergencies. Specifically, the Food and Drug Administration (FDA) must issue guidance on decentralized clinical trials to promote meaningful demographic and geographic diversity in patient engagement, enrollment, and participation. Decentralized clinical trials include those executed through telemedicine or other digital technologies to allow for the remote collection and assessment of clinical trial data. The FDA may also work with foreign regulators to harmonize international regulations governing decentralized clinical trials and the use of digital health technology. In addition, the Department of Health and Human Services (HHS) may support community education, outreach, and recruitment activities for clinical trials of treatments for conditions that disproportionately impact populations underrepresented in clinical trials. The bill also specifies that drug or device manufacturers may provide, subject to some limits, free digital health technologies and other remuneration to patients in approved clinical trials without violating laws that address fraud and abuse in federal programs. Furthermore, laboratories that test for and diagnose COVID-19 must report additional demographic data, including information about social determinants of health. HHS must also contract with the National Academy of Medicine to study and propose a design for an interoperable platform to facilitate data sharing during public health emergencies.

In committee Aug 10, 2021 1 co-sponsor
Showing 751 to 760 of 940 bills
Previous 1 … 75 76 77 … 94 Next